Neurostimulation Devices Market Size, Industry Report, 2023

1
Neurostimulation devices Market 2016 2023
2
Global Market Scenario of Neurostimulation devices

• Neurostimulation devices market size was valued
  at USD 4.6 billion in 2015, with forecast target
  exceeding USD 13.7 billion by 2023, at over 14.7
  CAGR.
• Growing base of geriatric population globally,
  coupled increasing prevalence of brain related
  disorders such as Epilepsy and Migraine are the
  pivotal factors driving global neurostimulation
  devices market size.
• WHO estimates the global prevalence of epilepsy
  to be 50 million, while the prevalence of
  migraine is estimated to be 40 million in 2011 in
  the U.S. Alone.
• Neurostimulation devices are crucial in providing
  therapeutic solutions for brain related
  disorders therefore rise in the prevalence of
  such diseases should drive the global
  neurostimulation devices market size during the
  forecast period.
• https//www.gminsights.com/industry-analysis/neur
  ostimulation-devices-market

3
Continue.....

• The industry is also witnessing various
  technological advancements such as minimally
  invasive transdermal neuromodulation technology,
  MRI safety incorporated devices. 
• A vast number of manufacturers are investing into
  rigorous research and development activities to
  develop new products enabled with advanced
  technologies.
• Growing demand for minimally invasive surgeries
  should also act as a catalyst for market growth,
  since neurostimulation device implantation is
  minimally invasive in nature.
• https//www.gminsights.com/industry-analysis/neuro
  stimulation-devices-market

4
Europe neurostimulation devices market Size, by
product, 2014-2023, (USD Million)

https//www.gminsights.com/industry-analysis/neuro
stimulation-devices-market
5
360 Analysis

• Application Analysis
• Pain management is identified to be the dominant
  application segment with target market size
  exceeding USD 9.5 billion by 2023. High global
  prevalence of chronic pain disorders and the
  growing adoption rates of neurostimulation
  devices for pain management on account of their
  high therapeutic value are significant factors
  contributing to its market growth.
• Regional Analysis
• North America, dominated by the U.S.
  neurostimulation devices market size is forecast
  to exceed USD 7.6 billion by 2023
• APAC, with demand being led by China, Japan, and
  India neurostimulation devices market share, is
  likely to witness over 17.9 revenue growth
  through 2023. 
• Competitive Market Share
• Global neurostimulation devices market share is
  led by Medtronic, Inc. St. Jude Medical, which
  accounted for approximately 65 share in 2015. 
• Other active players in this market include
  Boston Scientific Corporation, Cyberonics, Nevro
  Corporation, and Neuronetics, Inc. among others.
  Acquisitions and strategic alliances is the major
  strategy adopted by the players in this market,
  in order to maintain leadership position.

6

Latest Research Report On Neurostimulation
Devices Market _at_ https//www.gminsights.com/indust
ry-analysis/neurostimulation-devices-market
Download Latest Report PDF _at_ https//www.gminsig
hts.com/request-sample/detail/436
7
Stay In Touch You can visit us at
www.gminsights.com